BioCentury
ARTICLE | Company News

Dyax, CropTech Development Corp. deal

October 13, 1997 7:00 AM UTC

The companies will develop a biopharmaceutical production system based on CropTech's use of transgenic plants to express proteins and peptides, and Dyax's phage display methods of protein purification. The collaboration will focus on systems that produce high volume proteins such as insulin, glycoproteins, and bio-active proteins such as growth hormones (see Technology Briefing, BioCentury Part I). ...